Abstract TP67: Know Your Numbers: Refining the Stroke Alert Process for Hospitalized Patients

Tiffany O Sheehan,Tracie Schroeder,Wendy Kramer,Wendy Warga-Lopez,Ina Reynolds,Audra Williams,Madona Plueger
DOI: https://doi.org/10.1161/str.55.suppl_1.tp67
IF: 10.17
2024-02-01
Stroke
Abstract:Background and Issues: Patients who experience an in-hospital stroke often have delayed treatment compared with patients presenting to the ED. AHA Scientific Statement on Best Practices to Improve Management of In-Hospital Stroke recommends a targeted QI team to address barriers to treatment. Purpose: To establish a targeted QI team to evaluate in-hospital stroke alert (SA) response times, identify performance opportunities and develop an improvement plan. Methods: A QI team was formed in Jan 2023. Data were collected from the EHR and analyzed (i.e., symptom discovery to SA, SA to response team arrival, arrival of response team to imaging, imaging to treatment). Barriers to timely treatment were identified through the use of case timelines and stroke nurse champion focus groups. One barrier identified was the use of a non-emergent operator vs. the emergency hotline to activate a SA. Use of the non-emergent line left staff placed on hold, resulting in a delay of SA activation. In March 2023, PDSA cycle #1, use of the emergent hotline, was implemented and house wide staff education were administered addressing the process change. Results: Data were collected between Dec 2022-June 2023. There were a total of 64 SA activations, 53% were activated on a non-neuroscience unit, and 33% were diagnosed with a stroke. Three patients were treated with a thrombolytic (n=2, avg. 47 min) or thrombectomy (n=1, 55 min). Prior to implementation (Dec-Feb 2023) symptom discovery to SA averaged 8 minutes (n=28) and remained unchanged post implementation (April-June 2023, avg. 8 min, n=36). Conclusion: A targeted QI team focused on in-hospital SA processes showed benefit by identifying opportunities to decrease time to treatment. No change was seen in the avg time from symptom discovery to activation. Future areas of opportunity include focused education on non-neuroscience units and strategies aimed at decreasing the time from SA to imaging interpreted.
peripheral vascular disease,clinical neurology
What problem does this paper attempt to address?